title: Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.
abstract: We describe the chimerization of a monoclonal antibody directed against the c-erbB-2 protein using a novel PCR method for cloning immunoglobulin variable region genes. We also describe the characterization of the chimera and show its potential use for treating cancers which overexpress the c-erbB-2 protein. The genomic DNA fragments of heavy and light chain variable genes were cloned by PCR using uniquely designed primers which allowed for isolation of genes containing functional promoters, signal and coding sequences. The chimeric genes were then constructed by linking variable regions of murine genes to human constant gamma 1 and kappa genes. Expression of the chimeric immunoglobulin genes resulted in production of properly assembled chimeric antibody with improved biological properties.
authors.affiliation: Department of Cell and Molecular Biology, Berlex Biosciences, Richmond, CA, USA.
authors.forename: H L
authors.initials: HL
authors.lastname: Liu
authors.forename: D L
authors.initials: DL
authors.lastname: Parkes
authors.forename: B C
authors.initials: BC
authors.lastname: Langton
authors.forename: J A
authors.initials: JA
authors.lastname: Xuan
authors.forename: M
authors.initials: M
authors.lastname: Longhi
authors.forename: S S
authors.initials: SS
authors.lastname: Elliger
authors.forename: L A
authors.initials: LA
authors.lastname: Chao
authors.forename: M P
authors.initials: MP
authors.lastname: McGrogan
authors.forename: J W
authors.initials: JW
authors.lastname: Brandis
authors.forename: L K
authors.initials: LK
authors.lastname: Shawver
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D003001:Cloning, Molecular; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007147:Immunoglobulin Light Chains / Q000235:genetics; D007167:Immunotherapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009374:Neoplasms, Experimental / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000276:immunology; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D018719:Erb-b2 Receptor Tyrosine Kinases; D011993:Recombinant Fusion Proteins